Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives.

Barcellini W, Fattizzo B, Zaninoni A.

J Blood Med. 2019 Aug 8;10:265-278. doi: 10.2147/JBM.S190327. eCollection 2019.

2.

Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.

Grace RF, Rose C, Layton DM, Galactéros F, Barcellini W, Morton DH, van Beers EJ, Yaish H, Ravindranath Y, Kuo KHM, Sheth S, Kwiatkowski JL, Barbier AJ, Bodie S, Silver B, Hua L, Kung C, Hawkins P, Jouvin MH, Bowden C, Glader B.

N Engl J Med. 2019 Sep 5;381(10):933-944. doi: 10.1056/NEJMoa1902678.

PMID:
31483964
3.

Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome: From Megakaryopoiesis to Immunomodulation.

Fattizzo B, Levati G, Cassin R, Barcellini W.

Drugs. 2019 Aug;79(12):1305-1319. doi: 10.1007/s40265-019-01159-0. Review.

PMID:
31292909
4.

Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag.

Fattizzo B, Cavallaro F, Milesi G, Barcellini W.

Am J Hematol. 2019 Jun 6. doi: 10.1002/ajh.25550. [Epub ahead of print] No abstract available.

PMID:
31172568
5.

Clinical and Molecular Spectrum of Glucose-6-Phosphate Isomerase Deficiency. Report of 12 New Cases.

Fermo E, Vercellati C, Marcello AP, Zaninoni A, Aytac S, Cetin M, Capolsini I, Casale M, Paci S, Zanella A, Barcellini W, Bianchi P.

Front Physiol. 2019 May 7;10:467. doi: 10.3389/fphys.2019.00467. eCollection 2019.

6.

Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome.

Lonati PA, Scavone M, Gerosa M, Borghi MO, Pregnolato F, Curreli D, Podda G, Femia EA, Barcellini W, Cattaneo M, Tedesco F, Meroni PL.

Front Immunol. 2019 Apr 12;10:773. doi: 10.3389/fimmu.2019.00773. eCollection 2019.

7.

Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag.

Fattizzo B, Kulasekararaj AG, Hill A, Benson-Quarm N, Griffin M, Munir T, Arnold L, Riley K, Ireland R, De Lavallade H, Potter V, Consonni D, Hillmen P, Mufti GJ, Barcellini W, Marsh JCW.

Haematologica. 2019 Nov;104(11):e494-e496. doi: 10.3324/haematol.2019.216374. Epub 2019 Mar 19. No abstract available.

8.

Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogs.

Fattizzo B, Pasquale R, Carpenedo M, Cantoni S, Auteri G, Gramegna D, D'Adda M, Napolitano M, Consonni D, Ruggeri M, Siragusa S, Rossi G, Vianelli N, Barcellini W.

Haematologica. 2019 Oct;104(10):e470-e473. doi: 10.3324/haematol.2019.216804. Epub 2019 Mar 7. No abstract available.

9.

Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation.

Barcellini W, Zaninoni A, Gregorini AI, Soverini G, Duca L, Fattizzo B, Giannotta JA, Pedrotti P, Vercellati C, Marcello AP, Fermo E, Bianchi P, Cappellini MD.

Br J Haematol. 2019 May;185(3):523-531. doi: 10.1111/bjh.15811. Epub 2019 Mar 3.

PMID:
30828802
10.

How we manage patients with pyruvate kinase deficiency.

Grace RF, Mark Layton D, Barcellini W.

Br J Haematol. 2019 Mar;184(5):721-734. doi: 10.1111/bjh.15758. Epub 2019 Jan 25. Review. Erratum in: Br J Haematol. 2019 May;185(4):807.

PMID:
30681718
11.

Low-dose rituximab in autoimmune hemolytic anemia: 10 years after.

Fattizzo B, Zaninoni A, Pettine L, Cavallaro F, Di Bona E, Barcellini W.

Blood. 2019 Feb 28;133(9):996-998. doi: 10.1182/blood-2018-12-885228. Epub 2019 Jan 22. No abstract available.

PMID:
30670440
12.

IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia.

Reda G, Cassin R, Gentile M, Mauro FR, Giannarelli D, Fattizzo B, Barbieri M, Silvestris I, Fabris S, Morabito F, Neri A, Barcellini W, Cortelezzi A.

Leukemia. 2019 Jun;33(6):1519-1522. doi: 10.1038/s41375-018-0344-1. Epub 2019 Jan 11. No abstract available.

PMID:
30635629
13.

Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderly.

Barcellini W, Fattizzo B, Cortelezzi A.

Eur J Intern Med. 2018 Dec;58:77-83. doi: 10.1016/j.ejim.2018.05.034. Review.

PMID:
30527923
14.

Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.

Bianchi P, Fermo E, Glader B, Kanno H, Agarwal A, Barcellini W, Eber S, Hoyer JD, Kuter DJ, Maia TM, Mañu-Pereira MDM, Kalfa TA, Pissard S, Segovia JC, van Beers E, Gallagher PG, Rees DC, van Wijk R; with the endorsement of EuroBloodNet, the European Reference Network in Rare Hematological Diseases.

Am J Hematol. 2019 Jan;94(1):149-161. doi: 10.1002/ajh.25325. Epub 2018 Nov 28.

PMID:
30358897
15.

A novel gain-of-function mutation of Piezo1 is functionally affirmed in red blood cells by high-throughput patch clamp.

Rotordam MG, Fermo E, Becker N, Barcellini W, Brüggemann A, Fertig N, Egée S, Rapedius M, Bianchi P, Kaestner L.

Haematologica. 2019 May;104(5):e179-e183. doi: 10.3324/haematol.2018.201160. Epub 2018 Sep 20. No abstract available.

16.

Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study.

van Beers EJ, van Straaten S, Morton DH, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Kwiatkowski JL, Rothman JA, Sharma M, Neufeld EJ, Sheth S, Despotovic JM, Kollmar N, Pospíšilová D, Knoll CM, Kuo K, Pastore YD, Thompson AA, Newburger PE, Ravindranath Y, Wang WC, Wlodarski MW, Wang H, Holzhauer S, Breakey VR, Verhovsek M, Kunz J, McNaull MA, Rose MJ, Bradeen HA, Addonizio K, Li A, Al-Sayegh H, London WB, Grace RF.

Haematologica. 2019 Feb;104(2):e51-e53. doi: 10.3324/haematol.2018.196295. Epub 2018 Sep 13. No abstract available.

17.

Current and emerging treatment options for autoimmune hemolytic anemia.

Barcellini W, Fattizzo B, Zaninoni A.

Expert Rev Clin Immunol. 2018 Oct;14(10):857-872. doi: 10.1080/1744666X.2018.1521722. Epub 2018 Oct 8. Review.

PMID:
30204521
18.

Utility of dynamic contrast-enhanced MRI to assess small bowel perfusion in paroxysmal nocturnal hemoglobinuria before and after eculizumab.

Barcellini W, Pezzetti G, Fattizzo B, Cavallaro F, De Cobelli F.

Eur J Intern Med. 2018 Nov;57:e25-e27. doi: 10.1016/j.ejim.2018.08.005. Epub 2018 Aug 17. No abstract available.

PMID:
30126686
19.

Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers.

Barcellini W, Zaninoni A, Fattizzo B, Giannotta JA, Lunghi M, Ferrari A, Leporace AP, Maschio N, Scaramucci L, Cantoni S, Chiurazzi F, Consonni D, Rossi G, De Fabritiis P, Gaidano G, Zanella A, Cortelezzi A.

Am J Hematol. 2018 Sep;93(9):E243-E246. doi: 10.1002/ajh.25212. Epub 2018 Aug 25. No abstract available.

20.

Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study.

Rossi G, Gramegna D, Paoloni F, Fattizzo B, Binda F, D'Adda M, Farina M, Lucchini E, Mauro FR, Salvi F, Marchetti M, Fazi P, Zaja F, Barcellini W.

Blood. 2018 Aug 2;132(5):547-550. doi: 10.1182/blood-2018-03-835413. Epub 2018 Jun 13. No abstract available.

PMID:
29898955
21.

Second-line therapy in paediatric warm autoimmune haemolytic anaemia. Guidelines from the Associazione Italiana Onco-Ematologia Pediatrica (AIEOP).

Ladogana S, Maruzzi M, Samperi P, Condorelli A, Casale M, Giordano P, Notarangelo LD, Farruggia P, Giona F, Nocerino A, Fasoli S, Casciana ML, Miano M, Tucci F, Casini T, Saracco P, Barcellini W, Zanella A, Perrotta S, Russo G; AIHA Committee of the Associazione Italiana di Ematologia ed Oncologia Pediatrica.

Blood Transfus. 2018 Jul;16(4):352-357. doi: 10.2450/2018.0024-18. Epub 2018 Apr 13. No abstract available.

22.

Use of Laser Assisted Optical Rotational Cell Analyzer (LoRRca MaxSis) in the Diagnosis of RBC Membrane Disorders, Enzyme Defects, and Congenital Dyserythropoietic Anemias: A Monocentric Study on 202 Patients.

Zaninoni A, Fermo E, Vercellati C, Consonni D, Marcello AP, Zanella A, Cortelezzi A, Barcellini W, Bianchi P.

Front Physiol. 2018 Apr 27;9:451. doi: 10.3389/fphys.2018.00451. eCollection 2018.

23.

Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.

Grace RF, Bianchi P, van Beers EJ, Eber SW, Glader B, Yaish HM, Despotovic JM, Rothman JA, Sharma M, McNaull MM, Fermo E, Lezon-Geyda K, Morton DH, Neufeld EJ, Chonat S, Kollmar N, Knoll CM, Kuo K, Kwiatkowski JL, Pospíšilová D, Pastore YD, Thompson AA, Newburger PE, Ravindranath Y, Wang WC, Wlodarski MW, Wang H, Holzhauer S, Breakey VR, Kunz J, Sheth S, Rose MJ, Bradeen HA, Neu N, Guo D, Al-Sayegh H, London WB, Gallagher PG, Zanella A, Barcellini W.

Blood. 2018 May 17;131(20):2183-2192. doi: 10.1182/blood-2017-10-810796. Epub 2018 Mar 16.

PMID:
29549173
24.

Paroxysmal Nocturnal Hemoglobinuria (Pnh): Brain Mri Ischemic Lesions In Neurologically Asymtomatic Patients.

Barcellini W, Scola E, Lanfranconi S, Grottaroli M, Binda F, Fattizzo B, Zaninoni A, Valcamonica G, Cinnante CM, Boschetti C, Buoli M, Altamura CA, Bresolin N, Triulzi F, Zanella A, Cortelezzi A.

Sci Rep. 2018 Jan 11;8(1):476. doi: 10.1038/s41598-017-18936-0.

25.

Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia.

Fattizzo B, Zaninoni A, Gianelli U, Zanella A, Cortelezzi A, Kulasekararaj AG, Barcellini W.

Am J Hematol. 2018 Aug;93(4):E88-E91. doi: 10.1002/ajh.25020. Epub 2018 Jan 10. No abstract available.

26.

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.

Cantoni S, Carpenedo M, Mazzucconi MG, De Stefano V, Carrai V, Ruggeri M, Specchia G, Vianelli N, Pane F, Consoli U, Artoni A, Zaja F, D'adda M, Visentin A, Ferrara F, Barcellini W, Caramazza D, Baldacci E, Rossi E, Ricco A, Ciminello A, Rodeghiero F, Nichelatti M, Cairoli R.

Am J Hematol. 2018 Jan;93(1):58-64. doi: 10.1002/ajh.24935. Epub 2017 Nov 9.

27.

The relationship between idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and autoimmunity.

Barcellini W.

Expert Rev Hematol. 2017 Jul;10(7):649-657. doi: 10.1080/17474086.2017.1339597. Epub 2017 Jun 15. Review.

PMID:
28586251
28.

Recommendations regarding splenectomy in hereditary hemolytic anemias.

Iolascon A, Andolfo I, Barcellini W, Corcione F, Garçon L, De Franceschi L, Pignata C, Graziadei G, Pospisilova D, Rees DC, de Montalembert M, Rivella S, Gambale A, Russo R, Ribeiro L, Vives-Corrons J, Martinez PA, Kattamis A, Gulbis B, Cappellini MD, Roberts I, Tamary H; Working Study Group on Red Cells and Iron of the EHA.

Haematologica. 2017 Aug;102(8):1304-1313. doi: 10.3324/haematol.2016.161166. Epub 2017 May 26.

29.

Paroxysmal nocturnal hemoglobinuria with spontaneous clinical remission.

Ferla V, Zaninoni A, Fattizzo B, Fermo E, Gianelli U, Barcellini W.

Eur J Intern Med. 2017 Sep;43:e11-e14. doi: 10.1016/j.ejim.2017.04.011. Epub 2017 May 18. No abstract available.

PMID:
28528998
30.

'Gardos Channelopathy': a variant of hereditary Stomatocytosis with complex molecular regulation.

Fermo E, Bogdanova A, Petkova-Kirova P, Zaninoni A, Marcello AP, Makhro A, Hänggi P, Hertz L, Danielczok J, Vercellati C, Mirra N, Zanella A, Cortelezzi A, Barcellini W, Kaestner L, Bianchi P.

Sci Rep. 2017 May 11;7(1):1744. doi: 10.1038/s41598-017-01591-w.

31.

Multifactorial neutropenia in a patient with acute promyelocytic leukemia and associated large granular lymphocyte expansion: A case report.

Reda G, Fattizzo B, Cassin R, Flospergher E, Orofino N, Gianelli U, Barcellini W, Cortelezzi A.

Oncol Lett. 2017 Mar;13(3):1307-1310. doi: 10.3892/ol.2016.5549. Epub 2016 Dec 28.

32.

Chronic lymphocytic leukemia and prognostic models: A bridge between clinical and biological markers.

Reda G, Cassin R, Fattizzo B, Giannarelli D, Mattiello V, Barcellini W, Cortelezzi A.

Am J Hematol. 2017 Jul;92(7):E135-E137. doi: 10.1002/ajh.24755. Epub 2017 May 26. No abstract available.

33.

Hereditary Xerocytosis due to Mutations in PIEZO1 Gene Associated with Heterozygous Pyruvate Kinase Deficiency and Beta-Thalassemia Trait in Two Unrelated Families.

Fermo E, Vercellati C, Marcello AP, Zaninoni A, van Wijk R, Mirra N, Curcio C, Cortelezzi A, Zanella A, Barcellini W, Bianchi P.

Case Rep Hematol. 2017;2017:2769570. doi: 10.1155/2017/2769570. Epub 2017 Mar 6.

34.

Diagnosis and management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the Red Cell Study Group of the Paediatric Haemato-Oncology Italian Association.

Ladogana S, Maruzzi M, Samperi P, Perrotta S, Del Vecchio GC, Notarangelo LD, Farruggia P, Verzegnassi F, Masera N, Saracco P, Fasoli S, Miano M, Girelli G, Barcellini W, Zanella A, Russo G; AIHA Committee of the Italian Association of Paediatric Onco-haematology (AIEOP).

Blood Transfus. 2017 May;15(3):259-267. doi: 10.2450/2016.0072-16. Epub 2016 Dec 16.

35.

Clinical evolution of autoimmune cytopenias to idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and bone marrow failure syndromes.

Barcellini W, Fattizzo B, Zaninoni A, Valli V, Ferri V, Gianelli U, Cortelezzi A.

Am J Hematol. 2017 Mar;92(3):E26-E29. doi: 10.1002/ajh.24618. Epub 2017 Feb 3. No abstract available.

36.

Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response.

Marangon M, Vianelli N, Palandri F, Mazzucconi MG, Santoro C, Barcellini W, Fattizzo B, Volpetti S, Lucchini E, Polverelli N, Carpenedo M, Isola M, Fanin R, Zaja F.

Eur J Haematol. 2017 Apr;98(4):371-377. doi: 10.1111/ejh.12839. Epub 2017 Jan 20.

PMID:
27981682
37.

Analysis of a cohort of 101 CDAII patients: description of 24 new molecular variants and genotype-phenotype correlations.

Bianchi P, Schwarz K, Högel J, Fermo E, Vercellati C, Grosse R, van Wijk R, van Zwieten R, Barcellini W, Zanella A, Heimpel H.

Br J Haematol. 2016 Nov;175(4):696-704. doi: 10.1111/bjh.14271. Epub 2016 Jul 29.

PMID:
27471141
38.

Detection of erythroblast antibodies in mitogen-stimulated bone marrow cultures from patients with myelodysplastic syndromes.

Zaninoni A, Imperiali FG, Cattaneo A, Soverini G, Binda F, Porretti L, Cortelezzi A, Barcellini W.

Transfusion. 2016 Aug;56(8):2037-41. doi: 10.1111/trf.13652. Epub 2016 May 27.

PMID:
27232106
39.

Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia.

Carrabba M, Barcellini W, Fabio G.

J Clin Immunol. 2016 Jul;36(5):434-6. doi: 10.1007/s10875-016-0282-5. Epub 2016 Apr 12. No abstract available.

PMID:
27072856
40.

Reduced 25-OH vitamin D in patients with autoimmune cytopenias, clinical correlations and literature review.

Fattizzo B, Zaninoni A, Giannotta JA, Binda F, Cortelezzi A, Barcellini W.

Autoimmun Rev. 2016 Jul;15(7):770-5. doi: 10.1016/j.autrev.2016.03.015. Epub 2016 Mar 14. Review.

PMID:
26988993
41.

Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.

Zaja F, Barcellini W, Cantoni S, Carpenedo M, Caparrotti G, Carrai V, Di Renzo N, Santoro C, Di Nicola M, Veneri D, Simonetti F, Liberati AM, Ferla V, Paoloni F, Crea E, Volpetti S, Tuniz E, Fanin R.

Am J Hematol. 2016 May;91(5):E293-5. doi: 10.1002/ajh.24341. Epub 2016 Apr 4.

42.

The clinical dilemma and management of red cell autoantibodies.

Barcellini W.

Expert Rev Hematol. 2016;9(4):325-7. doi: 10.1586/17474086.2016.1152885. Epub 2016 Feb 26. No abstract available.

PMID:
26864610
43.

Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia.

Barcellini W, Fattizzo B.

Dis Markers. 2015;2015:635670. doi: 10.1155/2015/635670. Epub 2015 Dec 27. Review.

44.

New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia.

Barcellini W.

Transfus Med Hemother. 2015 Sep;42(5):287-93. doi: 10.1159/000439002. Epub 2015 Sep 7. Review.

45.

Immune Hemolysis: Diagnosis and Treatment Recommendations.

Barcellini W.

Semin Hematol. 2015 Oct;52(4):304-12. doi: 10.1053/j.seminhematol.2015.05.001. Epub 2015 May 19. Review.

PMID:
26404442
46.

Current treatment strategies in autoimmune hemolytic disorders.

Barcellini W.

Expert Rev Hematol. 2015 Oct;8(5):681-91. doi: 10.1586/17474086.2015.1073105. Epub 2015 Jul 31. Review.

PMID:
26343892
47.

Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis.

Zaninoni A, Vercellati C, Imperiali FG, Marcello AP, Fattizzo B, Fermo E, Bianchi P, Grossi C, Cattaneo A, Cortelezzi A, Zanella A, Barcellini W.

Transfusion. 2015 Dec;55(12):2930-8. doi: 10.1111/trf.13257. Epub 2015 Aug 10.

PMID:
26259504
48.

Is chronic neutropenia always a benign disease? Evidences from a 5-year prospective study.

Fattizzo B, Zaninoni A, Consonni D, Zanella A, Gianelli U, Cortelezzi A, Barcellini W.

Eur J Intern Med. 2015 Oct;26(8):611-5. doi: 10.1016/j.ejim.2015.05.019. Epub 2015 Jun 8.

PMID:
26066399
49.

A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or Thrombocytopenia.

Motta I, Filocamo M, Poggiali E, Stroppiano M, Dragani A, Consonni D, Barcellini W, Gaidano G, Facchini L, Specchia G, Cappellini MD; Splenomegaly Gaucher Disease study group.

Eur J Haematol. 2016 Apr;96(4):352-9. doi: 10.1111/ejh.12596. Epub 2015 Jun 11.

PMID:
26033455
50.

Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias.

Fattizzo B, Zaninoni A, Nesa F, Sciumbata VM, Zanella A, Cortelezzi A, Barcellini W.

Am J Hematol. 2015 Aug;90(8):E149-51. doi: 10.1002/ajh.24047. No abstract available.

Supplemental Content

Loading ...
Support Center